Orchestra BioMed Holdings, Inc. (OBIO) income statement
OBIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/30
$7.46+0.49 (+7.03%)
Close on Nov 18, 2026Market cap $448.38MP/E –Yield –
Orchestra BioMed Holdings, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 99.5%
- Operating margin
- -181.4%
- Net margin
- -184.6%
- Return on equity, FY2025
- –
Financial strength
- Current ratio
- 8.26
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 152.0%
Valuation
- P/E ratio
- –
- Price to sales
- 14.02
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?